Advances in Ewing's sarcoma research: where are we now and what lies ahead?
- PMID: 19738075
- DOI: 10.1158/0008-5472.CAN-08-4041
Advances in Ewing's sarcoma research: where are we now and what lies ahead?
Abstract
Ewing's sarcoma family tumors (EFT) are characterized by specific chromosomal translocations, which lead to EWS/ETS transcription factors. Elucidation of EWS/ETS target gene networks within the context of other signaling pathways, together with the identification of the initiating cell, and the development of genetically engineered mice will hopefully lead to biology-based therapeutic strategies for these tumors.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
